Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CDIB Capital Group is a prominent private equity and venture capital firm headquartered in Taipei, Taiwan, operating as the investment arm of China Development Financial Holding. The firm maintains a robust focus on the healthcare and life sciences sectors, managing dedicated funds that target high-growth opportunities in biotechnology, medical technology, and healthcare services. CDIB Ventures provides growth capital and strategic support to innovative companies across Greater China, North America, and the Asia-Pacific region. Their investment strategy emphasizes supporting companies with strong potential for cross-border expansion and those addressing significant unmet medical needs. Beyond financial investment, the firm leverages its deep industry expertise and extensive regional network to assist portfolio companies with market entry and commercialization. Notable investments include a diverse range of biopharmaceutical and medtech firms, positioning CDIB as a key player in the global healthcare investment landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CDIB Ventures.